Beck PL - Search Results

1

Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease.

O'Connor PM, Lapointe TK, Beck PL, Buret AG. O'Connor PM, et al. Among authors: beck pl. Inflamm Bowel Dis. 2010 Aug;16(8):1411-20. doi: 10.1002/ibd.21217. Inflamm Bowel Dis. 2010. PMID: 20155848 Review.

2

Growth factors in inflammatory bowel disease.

Beck PL, Podolsky DK. Beck PL, et al. Inflamm Bowel Dis. 1999 Feb;5(1):44-60. doi: 10.1097/00054725-199902000-00007. Inflamm Bowel Dis. 1999. PMID: 10028449 Review.

3

A role for proteinase-activated receptor-1 in inflammatory bowel diseases.

Vergnolle N, Cellars L, Mencarelli A, Rizzo G, Swaminathan S, Beck P, Steinhoff M, Andrade-Gordon P, Bunnett NW, Hollenberg MD, Wallace JL, Cirino G, Fiorucci S. Vergnolle N, et al. J Clin Invest. 2004 Nov;114(10):1444-56. doi: 10.1172/JCI21689. J Clin Invest. 2004. Retraction in: J Clin Invest. 2006 Jul;116(7):2056. doi: 10.1172/jci21689r1. PMID: 15545995 Free PMC article. Retracted.

4

Advances in medical therapy of inflammatory bowel disease.

Panaccione R, Ferraz JG, Beck P. Panaccione R, et al. Curr Opin Pharmacol. 2005 Dec;5(6):566-72. doi: 10.1016/j.coph.2005.08.003. Epub 2005 Oct 6. Curr Opin Pharmacol. 2005. PMID: 16213789 Review.

5

Cytokines in inflammatory bowel disease.

Beck PL, Wallace JL. Beck PL, et al. Mediators Inflamm. 1997;6(2):95-103. doi: 10.1080/09629359791785. Mediators Inflamm. 1997. PMID: 18472842 Free PMC article.

6

Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura.

Jackson SC, Beck P, Buret AG, O'Connor PM, Meddings J, Pineo G, Poon MC. Jackson SC, et al. Int J Hematol. 2008 Sep;88(2):212-218. doi: 10.1007/s12185-008-0138-8. Epub 2008 Aug 1. Int J Hematol. 2008. PMID: 18668306 Clinical Trial.

7

Evidence of endothelial dysfunction in patients with inflammatory bowel disease.

Roifman I, Sun YC, Fedwick JP, Panaccione R, Buret AG, Liu H, Rostom A, Anderson TJ, Beck PL. Roifman I, et al. Among authors: beck pl. Clin Gastroenterol Hepatol. 2009 Feb;7(2):175-82. doi: 10.1016/j.cgh.2008.10.021. Epub 2008 Oct 30. Clin Gastroenterol Hepatol. 2009. PMID: 19121648

8

Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease.

Hirota SA, Beck PL, MacDonald JA. Hirota SA, et al. Among authors: beck pl. Recent Pat Inflamm Allergy Drug Discov. 2009 Jan;3(1):1-16. doi: 10.2174/187221309787158434. Recent Pat Inflamm Allergy Drug Discov. 2009. PMID: 19149741 Review.

9

NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis.

Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, Lam V, Potentier MS, Ng K, Bawa M, McCafferty DM, Rioux KP, Ghosh S, Xavier RJ, Colgan SP, Tschopp J, Muruve D, MacDonald JA, Beck PL. Hirota SA, et al. Among authors: beck pl. Inflamm Bowel Dis. 2011 Jun;17(6):1359-72. doi: 10.1002/ibd.21478. Epub 2010 Sep 24. Inflamm Bowel Dis. 2011. PMID: 20872834 Free PMC article.

10

Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells.

O'Connor PM, Lapointe TK, Jackson S, Beck PL, Jones NL, Buret AG. O'Connor PM, et al. Among authors: beck pl. Infect Immun. 2011 Oct;79(10):3887-94. doi: 10.1128/IAI.05109-11. Epub 2011 Aug 8. Infect Immun. 2011. PMID: 21825064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters